AS is activated after MS lesions, releasing inflammatory mediators and cytokines such as IL‐1β and TNF‐α, participating in inflammatory reactions, and can also produce neurotrophic factors such as nerve growth factor (NGF) to support the survival and differentiation of OLs. This evidence concerns the gene NGF and myeloid sarcoma.